text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 252917-06-9 | Product Number: C2943

CHIR 99021


Purity: >97.0%(HPLC)
Synonyms:
  • 6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile
Product Documents:
25MG
150,00 €
3   35  
100MG
402,00 €
1   18  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number C2943
Purity / Analysis Method >97.0%(HPLC)
Molecular Formula / Molecular Weight C__2__2H__1__8Cl__2N__8 = 465.34 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (-20°C)
Condition to Avoid Heat Sensitive
Packaging and Container 100MG-Glass Bottle with Plastic Insert (View image),  25MG-Glass Bottle with Plastic Insert (View image)
CAS RN 252917-06-9
Reaxys Registry Number 25763160
PubChem Substance ID 468591053
MDL Number

MFCD11846251

Specifications
Appearance White to Light yellow to Light orange powder to crystal
Purity(HPLC) min. 97.0 area%
Properties (reference)
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P261 : Avoid breathing dust.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell.
P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell.
Related Laws:
Transport Information:
HS Number 2933599590
Application
Research on regenerative medicine

CHIR 99021 is also used with XAV 939 as a key component for mouse epiblast stem cell and human embryonic stem cell self-renewal.1) Under cytokine-free conditions, the combination of CHIR 99021 and the mTOR inhibitor, rapamycin, maintains mouse and human hematopoietic stem cells.2) In the presence of CHIR 99021, OCT4-transduced human blood CD34+ cells are converted into induced mesenchymal stem cells (iMSCs).3)

References


Application
CHIR 99021: A Specific Glycogen Synthase Kinase 3 (GSK3) Inhibitor

CHIR 99021 is a specific glycogen synthase kinase 3 (GSK3) inhibitor. GSK3 is a serine/threonine kinase that mediates the addition of phosphate molecules onto serine and threonine amino acid residues, and that plays a key role in both the insulin and Wnt signaling pathways.1,2) CHIR 99021 specifically inhibits the GSK3 pathway.3,4)

References


Articles/Brochures

Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.